TECXTectonic Therapeutic, Inc.
$22.68+52% 1Y
$22.68
$15.3652 weeks$37.82
TECX in its own filings
TECX's filing record carries one kind of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
186
Events found in the filings · across 578 filings · the record starts in 2018
- Hard flags
- 1
Hard flags
- Most recent filing
- Sep 29, 2026
Most recent filing · Form 8-K
- Record starts
- May 7, 2018
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 5, 2026
- Change in certifying accountantpast_3y
- 2024-06-20
- Delisting notice / listing-rule failurehistorical
- 2022-10-07
- SEC comment-letter activity27 occurrences
- 2025-07-11
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 29, 2026On September 29, 2026, Tectonic Therapeutic, Inc. issued a press release titled “Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)”Other event · Form 8-K
- Aug 6, 2026Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights.Earnings release · press release
- Jun 10, 2026On June 8, 2026, Tectonic Therapeutic, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 13, 2026, the record date for the Annual Meeting, 18,848,500 shares of common stock were outstanding and entitled to vote at the Annual Meeting.Shareholder vote results · Form 8-K
- May 7, 2026Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights.Earnings release · press release
- Apr 23, 2026On April 23, 2026, the Board of Directors (the “Board”) of Tectonic Therapeutic, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Jessica Chutter as a member of the Board and as a member of the Audit Committee of the Board (the “Audit Committee”) …Director or officer change · Form 8-K
- Feb 26, 2026Tectonic Therapeutic Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights.Earnings release · press release
- Feb 24, 2026On February 23, 2026, the Board of Directors (the “Board”) of Tectonic Therapeutic, Inc. (the “Company”), upon recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating and Corporate Governance Committee”), approved an increase in the size of the Board from six directors to …Director or officer change · Form 8-K
- Nov 6, 2025Tectonic Therapeutic Announces Third Quarter 2025 Financial Results and Recent Business Highlights.Earnings release · press release
- Oct 30, 20252 DISCLAIMER Statements contained in this presentation regarding matters.Other event · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…